Under construction – not a live service
Sign in
Taking people in SpainNo phase

Tests brain stimulation with neurofeedback for attention problems after brain injury

Tests electrical brain stimulation with neurofeedback training in adults with attention problems from brain injury.

Plain-language title generated from the registry record
Registry title: Effects of Neurofeedback Training and tRNS on Attentional Deficits in Patients With Acquired Brain Injury

Key facts

Where
Valencia, SpainSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT07817316, who can take part

Where in Spain

  • Hospitales VithasValencia, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Hospitales Nisa
Trial code
NCT07817316
Record updated
14 September 2026
Original description
The goal of this study is to investigate new neuromodulation therapies for attention deficits following acquired brain injury. Brain damage can affect various domains, including motor and cognitive functions. However, cognitive deficits have many consequences on the functionality and independence of patients, and attention is an essential requirement for most of daily activities. After brain damage, cognitive rehabilitation is generally the first treatment option for attention deficits. Some studies have shown that cognitive rehabilitation is sometimes not very effective.For this reason, new therapies such as neuromodulation techniques are being investigated. Neurofeedback is a non-invasive neuromodulation therapy involving a type of computer-based training and learning, and some studies have shown that it is a promising tool to treat cognitive deficits in patients with brain injuries. Transcranial electrical stimulation (tES) is also used to modulate spontaneous brain activity. In the present study, the investigators will evaluate the effects of tES combined with neurofeedback as a therapy for attentional deficits after brain injury.Read full original descriptionShow less

Effects of Neurofeedback Training and tRNS on Attentional Deficits in Patients With Acquired Brain Injury

The goal of this study is to investigate new neuromodulation therapies for attention deficits following acquired brain injury. Brain damage can affect various domains, including motor and cognitive functions. However, cognitive deficits have many consequences on the functionality and independence of patients, and attention is an essential requirement for most of daily activities. After brain damage, cognitive rehabilitation is generally the first treatment option for attention deficits. Some studies have shown that cognitive rehabilitation is sometimes not very effective.For this reason, new therapies such as neuromodulation techniques are being investigated. Neurofeedback is a non-invasive neuromodulation therapy involving a type of computer-based training and learning, and some studies have shown that it is a promising tool to treat cognitive deficits in patients with brain injuries. Transcranial electrical stimulation (tES) is also used to modulate spontaneous brain activity. In the present study, the investigators will evaluate the effects of tES combined with neurofeedback as a therapy for attentional deficits after brain injury.

Inclusion: ≥18 years old; ABI resulting from TBI, stroke, hypoxia and other etiologies; attentional deficits that are among the objectives of neurorehabilitation as established by the clinical team (scores falling in the 90% percentiles on the Conner's Continuous Performance - CCPT, on the Digit and Spatial Span Tasks and Color Trail test); good cognitive condition (ie., scores of ≥23 in the Mini Mental State Examination; MMSE or ≥75 in the Galveston Orientation \& Amnesia Test - GOAT).

Exclusion: previous report of psychiatric and/or neurologic disorders; contraindication to computerized activities; blindness or severe visual impairments.

ClinicalTrials.gov NCT07817316